1. The Impact of Tamsulosin Oral Controlled Absorption System (OCAS) on Nocturia and the Quality of Sleep: Preliminary Results of a Pilot Study 
Bob Djavan, Shirin Milani, Jonathan Davies, John Bolodeoku 
European Urology Supplements 
Volume 4, Issue 2, Pages (February 2005)
DOI: /j.eursup
Copyright © 2004 Elsevier B.V. Terms and Conditions

2. Fig. 1
Main causes of disturbed sleep maintenance in elderly men aged 50–93 years [6].
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

3. Fig. 2
Tamsulosin pk profiles of tamsulosin OCAS steady state (study 617cl302) and tamsulosin modified release steady state (study YM12617).
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

4. Fig. 3
Mean increase of hours of undisturbed sleep from baseline to endpoint (FAS).
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

5. Fig. 4
Mean decrease in nocturnal voids from baseline to endpoint (FAS).
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

6. Fig. 5 Effect of treatment on mean total I-PSS over time (FAS).
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

7. Fig. 6
Mean decrease I-PSS nocturnia sub-score voids from baseline to endpoint (FAS).
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions

8. Fig. 7
Mean decrease I-PSS quality of life (QoL) from baseline to endpoint (FAS).
European Urology Supplements 2005 4, 61-68DOI: ( /j.eursup )
Copyright © 2004 Elsevier B.V. Terms and Conditions